Christopher v. SmithKline Beecham Corp. (11-204)

Summarized by:

  • Court: U.S. Supreme Court Certiorari Granted
  • Area(s) of Law: Administrative Law
  • Date Filed: November 28, 2011
  • Case #: 11-204
  • Judge(s)/Court Below: 635 F.3d 383 (9th Cir. 2011)
  • Full Text Opinion

(1) Whether deference is owed to the to the Secretary of Labor’s interpretation of the Fair Labor Standards Act’s sales exemption; and (2)whether the FLSA’s outside sale exemption applies to pharmaceutical sales representatives.

The Pharmaceutical industry regularly considers pharmaceutical sales representatives (PSRs) as outside sales employees. Outside sales employees is a class that is exempt from the overtime provision protections of the Fair Labor Standards Act (FLSA). In the amicus brief filed in the Second Circuit in Novartis Pharm. Corp. v. Lopes, 611 F.3d 141 (2d Cir. 2010), the Department of Labor interprets PSRs as non-exempt and entitled to overtime pay. The Second Circuit deferred to the DOL’s interpretations concluding that PSRs do not make sales and are, therefore, not outside salesmen.

Michael Christopher and Frank Buchanan, both PSRs, filed suit under the FLSA seeking overtime pay on behalf of the PSR class employed by SmithKline Beecham Corp. (dba GSK). The Ninth Circuit did not defer to the DOL in its decision and instead concluded that PSRs qualify for the FLSA exemption even though other industry regulation limits PSRs from making traditional sales.

Advanced Search